Filter Results
:
(115)
Show Results For
-
All HBS Web
(277)
- News (119)
- Research (115)
- Events (3)
- Multimedia (3)
- Faculty Publications (60)
Show Results For
-
All HBS Web
(277)
- News (119)
- Research (115)
- Events (3)
- Multimedia (3)
- Faculty Publications (60)
Sort by
- 29 May 2014
- Research & Ideas
Research Symposium 2014
particular ailment. A patient would visit a primary care physician in one location, an outpatient specialist in another, an imaging center in another, a blood lab in another, a surgeon in another, and so on. "The patient was a ping pong...
View Details
- 22 Jan 2008
- Research & Ideas
New Challenges in Leading Professional Services
past, the work of PSFs was a gentleman's game—and now it's blood sport." Adding to the problem is the fact that many current leaders are overwhelmed trying to balance their dual roles of producer and manager. What's needed, DeLong...
View Details
- 17 Nov 2003
- Research & Ideas
The Business Case for Diabetes Disease Management
it. "We have the medical knowledge to do it. And it's not being done. Just under one-half of identified diabetics in this country don't have their blood sugar under control," she said. Diabetes manifests as Type I or Type II...
View Details
- 18 Jun 2001
- Research & Ideas
When In-House Research Isn’t Enough
owe their life's blood to PARC—Adobe, SynOptics, VLSI, and 3Com, for example—together recorded a market value last year five or six times greater than that of mother Xerox. "By focusing too narrowly on its core, vertically-integrated...
View Details
Keywords:
by Jim Aisner
- 26 Sep 2017
- First Look
First Look at New Research and Ideas, September 26, 2017
Business School Case 817-060 RubiconMD No abstract available. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/817060-PDF-ENG Harvard Business School Case 517-127 Theranos: Small Volume Blood Testing (A) No abstract available....
View Details
Keywords:
Sean Silverthorne
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
already have products on the market, as does Amgen, where Gordon M. Binder (MBA '62) served as CEO until his retirement last month (he will continue to serve as chairman through December). Amgen's Epogen (a treatment for anemia in kidney dialysis patients) and Neupogen...
View Details
- 24 Sep 2007
- Research & Ideas
The FDA: What Will the Next 100 Years Bring?
state after an outbreak of illness. Approved the first generic versions of Coreg, a widely used medication for high blood pressure and chronic heart failure. Proposed new standards for formulating, testing, and labeling sunscreen drug...
View Details
- 24 Mar 2020
- Research & Ideas
These Coronavirus Heroes Show Us How Crisis Leadership Works
tests for COVID-19 in their labs as pressure mounts for rapid and accurate test results. LabCorp and Quest, the world’s largest blood testing agencies, weren’t engaged to take on this Herculean task until March 13 because the Centers for...
View Details
- 26 Jun 2009
- Research Event
Business Summit: Business and the Environment
Managing Partner, Generation Investment ManagementJames McCarthy, Harvard University faculty These experts shared their perspectives on global climate change. Professor McCarthy discussed scientific findings; Blood provided an investor's...
View Details
- 23 Mar 2020
- Research & Ideas
Product Disasters Can Be Fertile Ground for Innovation
discovered that the error was made a year before when it had reconfigured a scanner to improve doctors’ ability to see blood flow in the brain. More than 200 patients had suffered the same fate, receiving up to eight times the normal dose...
View Details
- 10 May 2011
- First Look
First Look: May 10
but also that NEAD chains produced more transplants for highly sensitized and blood type O recipients. Read the paper: http://kuznets.fas.harvard.edu/~aroth/papers/Nonsimultaneous%20Chains%20AJT%202011.pdf Female Empowerment: Impact of a...
View Details
Keywords:
Sean Silverthorne
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
Pharmacyclics is a biotechnology company that had received FDA approval in late 2013 for its flagship asset Imbrivica (ibrutinib), a biologic treatment for chronic lymphocytic leukemia and two other even rarer blood malignancies. Entering...
View Details
Keywords:
Sean Silverthorne
- 28 Nov 2011
- Research & Ideas
Rethinking the Fairness of Organ Transplants
point system that takes into account a number of factors including the potential recipient's proximity to the available organ, blood type, life expectancy after a transplant, and various fairness criteria such as time waiting on the list....
View Details
- 21 Nov 2006
- First Look
First Look: November 21, 2006
blood or tissue incompatibility. Incompatible patient-donor pairs can exchange donor kidneys with other such pairs. The situation facing such pairs resembles models of the "double coincidence of wants," and relatively few...
View Details
Keywords:
Sean Silverthorne
- 15 Aug 2017
- First Look
First Look at New Research and Ideas, August 15, 2017
5,760 persons voluntarily opted for hypertension screening and received a single blood pressure measurement. In all, 1,783 (33.6%) screened positive, of whom 1,580 were previously unaware of their diagnosis. Of the 303 that previously had...
View Details
Keywords:
Sean Silverthorne
- 12 Aug 2014
- First Look
First Look: August 12
offer prevention-focused education, rewards for healthy behavior, and workplace environments that encouraged healthy employee behavior. By 2015, 90% of J&J's 128,000 employees would participate in Culture of Health programs; 80% would know their key health...
View Details
Keywords:
Sean Silverthorne
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
during all my consulting days before business school." DFA's breakthrough is a postage stamp-sized square that wicks biological fluids, such as blood or saliva, through treated paper to provide instant diagnostic results in parts of the...
View Details
- 17 Dec 2001
- Research & Ideas
Enterprising Women
people," said Cynthia Fisher (HBS MBA '90). In 1993, using her own capital, Fisher founded ViaCord, a business that allows customers to bank cord blood stem cells for possible future use in the treatment of cancer and autoimmune...
View Details
Keywords:
by Julia Hanna
- 13 May 2002
- Book
Bringing the Master Passions to Work
If passions are the masters of reason—as David Hume (1960) believed—then they have done a remarkable job at getting us to believe in their benign nature—their outright subservience to reason. Deception and self-deception are as critical to the narratives that the...
View Details
Keywords:
by Mihnea C. Moldoveanu & Nitin Nohria
- 03 Aug 2016
- Research & Ideas
Ominous Background Music Is Bad for Sharks
histrionic combination of blood and bubbles,” the researchers write. “Consequently, we propose that the background music in shark documentaries can negatively influence viewers’ perceptions of sharks, attitudes towards them, and...
View Details